- The value of volume
-
Wright JD
- KMID: 2536018
- J Gynecol Oncol.
- 2022 Jan;33(1):e17.
- doi: 10.3802/jgo.2022.33.e17
-
- CITED
-
- Close
- SHARE
-
- Close
- The course forward: next generation sequencing as part of the next generation management of patients with locally advanced cervical cancer
-
Markovina S
- KMID: 2536019
- J Gynecol Oncol.
- 2022 Jan;33(1):e20.
- doi: 10.3802/jgo.2022.33.e20
-
- CITED
-
- Close
- SHARE
-
- Close
- Impact of COVID-19 on gynecologic cancer treatment in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
-
Nogami Y, Komatsu H, Makabe T, Hasegawa Y, Yokoyama Y, Kawana K, Okamoto A, Mikami M, Katabuchi H, The COVID-19 Task Force of the Japan Society of Gynecologic Oncology
- KMID: 2536014
- J Gynecol Oncol.
- 2022 Jan;33(1):e8.
- doi: 10.3802/jgo.2022.33.e8
Objective As coronavirus disease 2019 (COVID-19) rages on, it is a challenging task to balance resources for treatment of COVID-19 and malignancy-based treatment. For the development of optimal strategies, assessing the... -
- CITED
-
- Close
- SHARE
-
- Close
- Total mesometrial resection (TMMR) for cervical cancer FIGO IB–IIA: first results from the multicentric TMMR register study
-
Buderath P, Stukan M, Ruhwedel W, Strutas D, Feisel-Schwickardi G, Wimberger P, Kimmig R
- KMID: 2536012
- J Gynecol Oncol.
- 2022 Jan;33(1):e9.
- doi: 10.3802/jgo.2022.33.e9
Objective The surgical concept of total mesometrial resection (TMMR) and therapeutic lymphadenectomy (tLNE) for the treatment of early cervical cancer is based on the ontogenetic cancer field model. Unicentric data show... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan: a JSOG tumor registry-based data extraction study
-
Machida H, Matsuo K, Oba K, Aoki D, Enomoto T, Okamoto A, Katabuchi H, Nagase S, Mandai M, Yaegashi N, Yamagami W, Mikami M
- KMID: 2536009
- J Gynecol Oncol.
- 2022 Jan;33(1):e3.
- doi: 10.3802/jgo.2022.33.e3
Objective Associations between hospital treatment volume and survival outcomes for women with 3 types of gynecologic malignancies, and the trends and contributing factors for high-volume centers were examined. Methods The Japan Society of... -
- CITED
-
- Close
- SHARE
-
- Close
- Cause-specific mortality rate of ovarian cancer in the presence of competing risks of death: a nationwide population-based cohort study
-
Shim SH, Lim MC, Lee D, Won YJ, Ha HI, Chang HK, Cho H
- KMID: 2536013
- J Gynecol Oncol.
- 2022 Jan;33(1):e5.
- doi: 10.3802/jgo.2022.33.e5
Objective This nationwide cohort study aimed to evaluate the cause-specific mortality (probability of death by ovarian cancer, probability of death by other causes) under the competing risks of death in women... -
- CITED
-
- Close
- SHARE
-
- Close
- Combined laparoscopic and transperineal endoscopic total pelvic exenteration for the vaginal stump recurrence of cervical cancer
-
Ohno R, Matsumoto Y, Nagano H, Komono A, Aisu N, Yoshimatsu G, Hasegawa S
- KMID: 2536017
- J Gynecol Oncol.
- 2022 Jan;33(1):e16.
- doi: 10.3802/jgo.2022.33.e16
Total pelvic exenteration (TPE) is sometimes required for radical treatment of locally advanced or recurrent gynecologic cancer [1]. However, TPE with a transabdominal approach requires highly advanced techniques in the... -
- CITED
-
- Close
- SHARE
-
- Close
- A novel gene signature associated with poor response to chemoradiotherapy in patients with locally advanced cervical cancer
-
Kim KH, Chang JS, Byun HK, Kim YB
- KMID: 2536011
- J Gynecol Oncol.
- 2022 Jan;33(1):e7.
- doi: 10.3802/jgo.2022.33.e7
Objective We aimed to investigate the distinct transcriptional landscape in poor responders to concurrent chemoradiotherapy (CCRT) and to gain mechanistic insights into treatment resistance in cervical cancer. Methods RNA sequencing was performed in... -
- CITED
-
- Close
- SHARE
-
- Close
- Circular RNA intraflagellar transport 80 facilitates endometrial cancer progression through modulating miR-545-3p/FAM98A signaling
-
Wang N, Guo Y, Song L, Tong T, Fan X
- KMID: 2536008
- J Gynecol Oncol.
- 2022 Jan;33(1):e2.
- doi: 10.3802/jgo.2022.33.e2
Objective Endometrial cancer (ECa) is a common gynecological malignancy. Circular RNAs (circRNAs) have been identified as key regulators of human tumorigenesis and development. Herein, we explored the role and mechanism of... -
- CITED
-
- Close
- SHARE
-
- Close
- Transabdominal cardiophrenic lymph node dissection for cytoreductive surgery in advanced ovarian cancer
-
Yang HC, Kim MS, Lee JM, Choi JH, Park SY
- KMID: 2536016
- J Gynecol Oncol.
- 2022 Jan;33(1):e6.
- doi: 10.3802/jgo.2022.33.e6
Objective Minimizing residual tumors is one of the most important prognostic factors in the management of advanced ovarian cancer [1]. In ovarian cancer patients with cardiophrenic lymph node (LN) metastases, transabdominal... -
- CITED
-
- Close
- SHARE
-
- Close
- Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic
-
Bogani G, Scambia G, Cimmino C, Fanfani F, Costantini B, Loverro M, Ferrandina G, Landoni F, Bazzurini L, Grassi T, Vitobello D, Siesto G, Perrone AM, Zanagnolo V, De Iaco P, Multinu F, Ghezzi F, Casarin J, Berretta R, Capozzi VA, Zupi E, Centini G, Pellegrino A, Corso S, Stevenazzi G, Montoli S, Boschi AC, Comerci G, Greco P, Martinello R, Sopracordevole F, Giorda G, Simoncini T, Caretto M, Sartori E, Ferrari F, Cianci A, Sarpietro G, Matarazzo MG, Zullo F, Bifulco G, Morelli M, Ferrero A, Biglia N, Barra F, Ferrero S, Maggiore ULR, Cianci S, Chiantera V, Ercoli A, Sozzi G, Martoccia A, Schettini S, Orlando T, Cannone FG, Ettore G, Puppo A, Borghese M, Martinelli C, Muzii L, Donato VD, Driul L, Restaino S, Bergamini A, Candotti G, Bocciolone L, Plotti F, Angioli R, Mantovani G, Ceccaroni M, Cassani C, Dominoni M, Giambanco L, Amodeo S, Leo L, Thomasset R, Raimondo D, Seracchioli R, Malzoni M, Gorlero F, Luca MD, Busato E, Kilzie S, Dell'Acqua A, Scarfone G, Vercellini P, Petrillo M, Dessole S, Capobianco G, Ciavattini A, Carpini GD
- KMID: 2536015
- J Gynecol Oncol.
- 2022 Jan;33(1):e10.
- doi: 10.3802/jgo.2022.33.e10
Objective Coronavirus disease 2019 (COVID-19) outbreak has correlated with the disruption of screening activities and diagnostic assessments. Endometrial cancer (EC) is one of the most common gynecological malignancies and it is... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary peritoneal cancer (ANZGOG1901/2020)
-
Farrell R, Burling M, Lee YC, Pather S, Robledo K, Mercieca-Bebber R, Stockler M, on behalf of the HyNOVA Protocol Steering Committee
- KMID: 2536007
- J Gynecol Oncol.
- 2022 Jan;33(1):e1.
- doi: 10.3802/jgo.2022.33.e1
Background Ovarian cancer is the most lethal gynecological cancer, causing over 200,000 deaths worldwide in 2020. Initial standard treatment for primary ovarian cancer is optimal cytoreductive surgery (CRS) preceded and/or followed... -
- CITED
-
- Close
- SHARE
-
- Close
- Accuracy of human papillomavirus tests on self-collected urine versus clinician-collected samples for the detection of cervical precancer: a systematic review and meta-analysis
-
Cho HW, Shim SR, Lee JK, Hong JH
- KMID: 2536010
- J Gynecol Oncol.
- 2022 Jan;33(1):e4.
- doi: 10.3802/jgo.2022.33.e4
Objective The human papillomavirus (HPV) test is an effective screening tool to prevent cervical cancer. Urinary sampling for HPV detection improves the accessibility and participation of screening services and reduces the... -
- CITED
-
- Close
- SHARE
-
- Close
